• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于促进鳞状细胞皮肤癌风险分层筛查的预测工具。

A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous Cell Skin Cancer.

机构信息

Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA.

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

出版信息

J Invest Dermatol. 2018 Dec;138(12):2589-2594. doi: 10.1016/j.jid.2018.03.1528. Epub 2018 Jul 2.

DOI:10.1016/j.jid.2018.03.1528
PMID:30472995
Abstract

Cutaneous squamous cell cancers (cSCCs) present an under-recognized health issue among non-Hispanic whites, one that is likely to increase as populations age. cSCC risks vary considerably among non-Hispanic whites, and this heterogeneity indicates the need for risk-stratified screening strategies that are guided by patients' personal characteristics and clinical histories. Here we describe cSCCscore, a prediction tool that uses patients' covariates and clinical histories to assign them personal probabilities of developing cSCCs within 3 years after risk assessment. cSCCscore uses a statistical model for the occurrence and timing of a patient's cSCCs, whose parameters we estimated using cohort data from 66,995 patients in the Kaiser Permanente Northern California healthcare system. We found that patients' covariates and histories explained approximately 75% of their interpersonal cSCC risk variation. Using cross-validated performance measures, we also found cSCCscore's predictions to be moderately well calibrated to the patients' observed cSCC incidence. Moreover, cSCCscore discriminated well between patients who subsequently did and did not develop a new primary cSCC within 3 years after risk assignment, with area under the receiver operating characteristic curve of approximately 85%. Thus, cSCCscore can facilitate more informed management of non-Hispanic white patients at cSCC risk. cSCCscore's predictions are available at https://researchapps.github.io/cSCCscore/.

摘要

皮肤鳞状细胞癌(cSCC)在非西班牙裔白种人群中是一个未被充分认识的健康问题,随着人口老龄化,这一问题可能会加剧。非西班牙裔白种人群中 cSCC 的风险差异很大,这种异质性表明需要根据患者的个人特征和临床病史制定风险分层筛查策略。在这里,我们描述了 cSCCscore,这是一种预测工具,它使用患者的协变量和临床病史为他们分配在风险评估后 3 年内发生 cSCC 的个人概率。cSCCscore 使用了一种用于患者 cSCC 发生和时间的统计模型,其参数是使用 Kaiser Permanente 北加州医疗保健系统的 66995 名患者的队列数据估计的。我们发现,患者的协变量和病史解释了大约 75%的人际 cSCC 风险变异。使用交叉验证的性能指标,我们还发现 cSCCscore 的预测与患者观察到的 cSCC 发生率具有中等程度的校准。此外,cSCCscore 很好地区分了在风险分配后 3 年内是否发生新的原发性 cSCC 的患者,其接受者操作特征曲线下的面积约为 85%。因此,cSCCscore 可以帮助更好地管理 cSCC 风险的非西班牙裔白种患者。cSCCscore 的预测结果可在 https://researchapps.github.io/cSCCscore/ 上获取。

相似文献

1
A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous Cell Skin Cancer.用于促进鳞状细胞皮肤癌风险分层筛查的预测工具。
J Invest Dermatol. 2018 Dec;138(12):2589-2594. doi: 10.1016/j.jid.2018.03.1528. Epub 2018 Jul 2.
2
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.全国范围内多发性与首次皮肤鳞状细胞癌的发病率及皮肤鳞状细胞癌未来发病率的估计。
JAMA Dermatol. 2020 Dec 1;156(12):1300-1306. doi: 10.1001/jamadermatol.2020.3677.
3
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.日光性皮肤损伤与随后发生的皮肤鳞状细胞癌的 10 年随访。
JAMA Dermatol. 2021 May 1;157(5):559-565. doi: 10.1001/jamadermatol.2021.0372.
4
Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.患有皮肤鳞状细胞癌的患者中后续皮肤鳞状细胞癌的风险因素和时间:一项回顾性队列研究。
J Am Acad Dermatol. 2021 Mar;84(3):719-724. doi: 10.1016/j.jaad.2020.08.083. Epub 2020 Aug 27.
5
Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.评估荷兰 1989-2017 年期间,既往原位皮肤鳞状细胞癌(cSCC)患者与普通人群相比,原位 cSCC 的发生率及发展为侵袭性 cSCC 的风险。
JAMA Dermatol. 2020 Sep 1;156(9):973-981. doi: 10.1001/jamadermatol.2020.1988.
6
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.年龄、性别、种族和地理位置与美国基底细胞癌与皮肤鳞状细胞癌比率变化的关联。
JAMA Dermatol. 2020 Nov 1;156(11):1192-1198. doi: 10.1001/jamadermatol.2020.2571.
7
Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.多发性皮肤鳞状细胞癌患者的预后:一项 10 年单机构队列研究。
JAMA Dermatol. 2015 Nov;151(11):1220-5. doi: 10.1001/jamadermatol.2015.1702.
8
Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.根据器官移植和血液系统恶性肿瘤患者分层的后续皮肤鳞状细胞癌的累积发病率和发病时间:一项全国性队列研究。
J Am Acad Dermatol. 2024 Mar;90(3):530-536. doi: 10.1016/j.jaad.2023.10.036. Epub 2023 Oct 21.
9
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.皮肤浸润性鳞状细胞癌的诊断与治疗:基于欧洲共识的跨学科指南
Eur J Cancer. 2015 Sep;51(14):1989-2007. doi: 10.1016/j.ejca.2015.06.110. Epub 2015 Jul 25.
10
Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.皮肤鳞状细胞癌:发病率、危险因素、诊断和分期。
J Am Acad Dermatol. 2018 Feb;78(2):237-247. doi: 10.1016/j.jaad.2017.08.059.

引用本文的文献

1
Rapidly Growing and Aggressive Squamous Cell Carcinoma of the Forearm: A Report of Successful Treatment With Mohs Surgery and Complex Reconstruction With Rhombic Triple Z-Plasty.前臂快速生长且侵袭性鳞状细胞癌:Mohs手术成功治疗及菱形三联Z成形术复杂重建的病例报告
Cureus. 2024 Feb 28;16(2):e55182. doi: 10.7759/cureus.55182. eCollection 2024 Feb.
2
Patterns and cost of care according to keratinocyte cancer risk stratification in a volunteer population screening clinic: Real-world data from the TRoPICS study.基于志愿者人群筛查诊所的角质形成细胞癌风险分层的护理模式和费用:来自 TRoPICS 研究的真实世界数据。
Australas J Dermatol. 2023 Aug;64(3):389-396. doi: 10.1111/ajd.14054. Epub 2023 Apr 24.
3
Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research.
皮肤癌筛查:识别高危亚组的重要性及美国人群研究的必要性
JAMA. 2023 Apr 18;329(15):1259-1260. doi: 10.1001/jama.2023.3259.
4
Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.为光化性角化病患者开发一种皮肤鳞状细胞癌风险预测模型。
Br J Dermatol. 2020 Sep;183(3):415-416. doi: 10.1111/bjd.18966. Epub 2020 May 10.
5
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.异基因造血细胞移植受者中角化细胞癌的风险因素。
JAMA Dermatol. 2020 Jun 1;156(6):631-639. doi: 10.1001/jamadermatol.2020.0559.
6
Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.日光性角化病患者皮肤角质形成细胞癌的预测:多变量风险预测模型的构建与内部验证
Br J Dermatol. 2020 Sep;183(3):495-502. doi: 10.1111/bjd.18810. Epub 2020 Feb 26.
7
Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?皮肤癌的全基因组关联研究和多基因风险评分:目前在临床上有用吗?
Br J Dermatol. 2019 Dec;181(6):1146-1155. doi: 10.1111/bjd.17917. Epub 2019 Jul 7.